NCT02574156 (CHyCS) is a Phase 3 clinical trial of Insulin in Hyperglycemia, sponsored by University of Sao Paulo.

Who is sponsoring NCT02574156?

NCT02574156 is sponsored by University of Sao Paulo.

What drugs are being tested in NCT02574156?

Interventions in NCT02574156: Insulin.

What condition does NCT02574156 study?

NCT02574156 studies Hyperglycemia.

Is NCT02574156 still recruiting?

NCT02574156 is currently terminated. Last updated 4 November 2022.

Last reviewed 2022-11-04 · How we verify

NCT02574156: CHyCS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Control of Hyperglycemia After Cardiac Surgery: CHyCS Trial

Terminated Phase 3 Last updated 4 November 2022

What this trial tests

Phase 3 trial testing Insulin in Hyperglycemia in 500 participants. Terminated before completion.

Timeline

1 January 2017

Primary endpoint
1 August 2018

1 April 2019

Quick facts

Lead sponsor	University of Sao Paulo
Phase	Phase 3
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	500
Start date	1 January 2017
Primary completion	1 August 2018
Estimated completion	1 April 2019
Sites	1 location across Brazil

Drugs / interventions tested

Insulin (insulin) — full drug profile →

Conditions studied

Hyperglycemia — all drugs for Hyperglycemia →

Sponsor

University of Sao Paulo

Who can join

18 and older, any sex, with Hyperglycemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to study the impact of a strategy of a intensive glycemic control in patients undergoing cardiac surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Insulin

Trials testing the same drug.

NCT07460336 — Effects of Cofrogliptin on Beta-Cell Function in LADA Patients · NA · not yet recruiting
NCT07259564 — A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD) · Phase 2 · not yet recruiting
NCT06762314 — Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes · Phase 2 · recruiting
NCT06781775 — GDM: Insulin with or Without Metformin? · Phase 4 · recruiting
NCT06391853 — Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study · NA · withdrawn

Other recruiting trials for Hyperglycemia

Currently open trials in the same condition.

NCT06893341 — Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events · NA · recruiting
NCT06118931 — Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic Control · NA · recruiting
NCT06184373 — Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot · recruiting
NCT07400549 — Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support T · NA · recruiting
NCT06694012 — Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 · recruiting

Other University of Sao Paulo trials

Trials by the same sponsor.

NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT07522554 — Lavender and Lemongrass Aromatherapy for Pain and Anxiety in Labor: A Randomized Trial · NA · active not recruiting
NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
NCT07445178 — Piecemeal Resection and Advanced Histology Independently Predict Local Recurrence After Colorectal Snare-based Endoscopi · completed
NCT07170007 — Physiotherapeutic Protocol Compared to Usual Care in the Treatment of Primiparas After Perineal Trauma · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02574156 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo
Last refreshed: 4 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02574156.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing